This element covers the advanced principles and practical applications of generating and utilizing genetically altered laboratory mice as models for human
Topic Synopsis
This element covers the advanced principles and practical applications of generating and utilizing genetically altered laboratory mice as models for human disease. It encompasses genome editing techniques, breeding strategies to maintain genetic integrity, quality control, and experimental design for conditional and inducible models. The unit also addresses the translational aspect of preclinical model selection, emphasizing conservation of physiology between species and the rigorous phenotyping required for robust scientific outcomes.
Key Concepts & Core Principles
- The 3Rs (Replacement, Reduction, Refinement) – a core ethical framework for minimising animal use and suffering in research.
- UK legislation: Animals (Scientific Procedures) Act 1986 (ASPA) and its amendments, including licensing requirements for establishments, projects, and individuals.
- Species-specific welfare assessment: recognising signs of pain, distress, and normal behaviour in rodents, rabbits, and other laboratory species.
- Environmental enrichment: designing housing and husbandry to promote natural behaviours and psychological well-being.
- Health monitoring and biosecurity: implementing sentinel programmes, quarantine protocols, and disease prevention strategies.
Exam Tips & Revision Strategies
- Clearly define the experimental unit and implement randomisation and blinding strategies in your experimental design to enhance rigour and reproducibility.
- When using conditional or inducible models, always validate the system in your specific context by demonstrating efficiency and specificity at the desired developmental time point.
- In breeding plans, perform power calculations early to determine cohort sizes, and choose breeding strategies that minimise animal usage while meeting statistical requirements.
- Reference international database identifiers and full nomenclature when describing strains to demonstrate meticulous sourcing and to facilitate reproducibility across laboratories.
- When selecting a preclinical model, explicitly map the molecular or physiological trait between mouse and human, and justify the model’s utility by citing conserved pathways and known drug responses.
Common Misconceptions & Mistakes to Avoid
- Assuming that genetically altered models on different genetic backgrounds will exhibit identical phenotypes, neglecting the influence of genetic drift and background modifiers.
- Failing to include appropriate controls in conditional experiments, such as omitting Cre-negative littermates or not validating the spatial and temporal activity of inducible systems.
- Misinterpreting strain nomenclature from repositories, leading to the selection of an incorrect strain or genetic tool for the intended study.
- Underestimating the impact of segregating a mixed genetic background over generations, which can confound phenotypic analysis.
- Overlooking the need to account for all animals in an experimental plan, including losses and adverse effects, which can compromise statistical power and reproducibility.
Examiner Marking Points
- Award credit for demonstrating a clear understanding of genome editing tools, such as CRISPR/Cas9, to introduce specific point mutations, including detail of guide RNA design and validation steps.
- Award credit for devising and justifying a breeding programme that selects an appropriate background strain, controls genetic drift, and adheres to Home Office and AWERB welfare restrictions.
- Award credit for evaluating the efficiency and specificity of conditional and inducible systems, including the design of relevant controls (e.g., floxed-only, Cre-only) and validation approaches.
- Award credit for locating and interpreting mouse strain information from international repositories, correctly using standard nomenclature and identifying key genetic tools such as recombinases.
- Award credit for incorporating power calculations to estimate cohort sizes in a breeding plan, and for explaining how to pool data across generations while accounting for potential confounding effects.
- Award credit for comparing methods of generating genetically altered models across species (e.g., fish, rats) and for evaluating how conservation or divergence of physiology impacts preclinical model utility.